The end of another year is fast approaching and I am left wondering, again, where did the last twelve months go? And of course, it’s a time for reflection on what our association accomplished in 2016 and to look ahead to what remains to be done.
I must offer my sincere thanks to the many of you who unfailingly contribute to our efforts. It goes without saying that without you we would achieve nothing, and it really important that we recognise this. And not least, on your behalf I extend our gratitude to our Secretariat, who always give of their very best to keep the ‘wheels of IPEC Europe’ turning without fail! The IPEC Europe board is also delighted that Adrian Bone joined the association as a senior adviser for IPEC Europe in June, and we thank him for his invaluable contribution over the last half year.
Of course, we will present more details on past and present objectives at our AGM in Monte-Carlo, which is now only a few weeks away. For me, 2016 has been a great year for execution and outreach to our broader community of key stakeholders. The Board has continued to consolidate our ‘2020 Vision’ in the form of a workplan which is driving a lot of the day-to-day activities of the Association. Some of our most valuable assets are IPEC Guidance documents and our committees and task forces have delivered yet again, revising the GDP, GMP and Quality Agreement guides and, all being well, they will be ready for launch at the beginning of 2017. This has been a great job as always and as these required close collaboration with sister IPECs and other organisations, they represent a global success.
It’s always good to be given the opportunity to share with regulators and various non-government organisations what IPEC is all about and 2016 has afforded us several such occasions. Through our interactions with EMA, EDQM, WHO and other European-based industrial association such as EFCG this year, we hope that we continue to spread the word about the unique perspective IPEC Europe can offer on all matters related to excipients. We extended this through our close relationships with the IPEC Federation and EXCiPACT and in 2017, we hope to be able to build on these interactions further. We also organised two successful conferences in Nice and Prague in 2016 with more than 200 participants. I must also mention the teams that were able to make the ‘How to’ guide for risk assessing for excipient GMP happen in April, followed by our first ever webinar on the same topic. Outstanding!
And so as I bring this editorial to a close, a final reminder of our annual Excipients Forum that will be held in Monte-Carlo on 1 February 2017. As always, it’s being held in combination with our Annual General Meeting, which takes place the following day. For more information about the programme and registration visit our website. I am looking forward to meeting many of you there.
Wishing you a wonderful holiday season and a healthy and prosperous 2017.